Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

111,Inc

Biotech & Life Sciences · Dongcheng District, China · Founded 2010 · IPO 2018 Thoroughbred

Operates as an online portal for selling pharmaceutical products

Valuation
$3.5M
Market cap · May/2026
Revenue
$1.98B
Latest reported FY
EBITDA
$3.5M
Latest reported FY

Investors

4 investors on 111,Inc's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Ivy Capital
Series B+ 3 investors entered at this stage
Verlinvest
ClearVue Partners
6 Dimensions Capital

Global footprint

Where 111,Inc has talent and traffic

Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown
Web traffic by country
480 monthly visits
across markets
🇨🇳 China63937.5%
🇺🇸 United States791.7%
🇻🇳 Vietnam729.2%
🇦🇺 Australia520.8%
🇨🇦 Canada458.3%
Top 5 markets shown

Market sentiment

What the market is saying about 111,Inc

An AI-synthesized read of the highest-engagement posts about 111,Inc on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See 111,Inc on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.